Albany Molecular Research Inc (AMRI) financial statements (2020 and earlier)

Company profile

Business Address 21 CORPORATE CIRCLE
ALBANY, NY 12203-5154
State of Incorp. DE
Fiscal Year End December 31
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments52494717623
Cash and cash equivalents52494717623
Restricted cash and investments034  
Receivables147116725242
Inventory, net of allowances, customer advances and progress billings16789503228
Inventory16789503228
Prepaid expense and other current assets7
Other undisclosed current assets2723181912
Total current assets:393280191279113
Noncurrent Assets
Property, plant and equipment365210165128136
Long-term investments and receivables 1111
Long-term investments 1111
Intangible assets, net (including goodwill)3962909433
Goodwill23116962  
Intangible assets, net (excluding goodwill)1651203333
Derivative instruments and hedges51765923 
Restricted cash and investments   45
Other noncurrent assets4357
Prepaid expense and other noncurrent assets2
Other undisclosed noncurrent assets15414
Total noncurrent assets:817585329166149
TOTAL ASSETS:1,210866520445263
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:11161322418
Employee-related liabilities1284  
Taxes payable3 041
Other undisclosed accounts payable and accrued liabilities9753282017
Debt3616021
Estimated litigation liability  013
Deferred revenue and credits13151177
Other undisclosed current liabilities1585107
Total current liabilities:17699494436
Noncurrent Liabilities
Long-term debt and lease obligation6043741601237
Long-term debt, excluding current maturities6043741601237
Liabilities, other than long-term debt13189693314
Deferred revenue and credits   23
Pension and other postretirement defined benefit plans, liabilities69
Accounts payable and accrued liabilities43   
Deferred tax liabilities, net40  11
Liability, pension and other postretirement and postemployment benefits1978
Other liabilities173211
Derivative instruments and hedges, liabilities51765923 
Other undisclosed noncurrent liabilities 16   
Total noncurrent liabilities:73547922915621
Total liabilities:91157827820057
Stockholders' equity
Stockholders' equity attributable to parent299287242246206
Common stock00000
Treasury stock, value(69)(68)(68)(67)(67)
Additional paid in capital400296244236208
Accumulated other comprehensive loss(40)(18)(14)(11)(10)
Retained earnings777808875
Total stockholders' equity:299287242246206
TOTAL LIABILITIES AND EQUITY:1,210866520445263

Income statement (P&L) ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
570402277247227
Cost of revenue(448)(296)(211)(175)(168)
Cost of goods and services sold(438)(296)(211)(175)(168)
Gross profit:123106667259
Operating expenses(141)(93)(80)(68)(72)
Other undisclosed operating income  201615
Operating income (loss):(19)146201
Nonoperating income (expense)(1)2(1)1(0)
Foreign currency transaction loss, before tax  (1)  
Other nonoperating income (expense)(1)2(0)1(0)
Interest and debt expense(40)(19)(11)(1)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes  1  
Income (loss) from continuing operations before income taxes:(60)(3)(5)200
Income tax expense (benefit)(10)12(7)(4)
Net income (loss) available to common stockholders, diluted:(70)(2)(3)13(4)

Comprehensive Income ($ in millions)

12/31/2016
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(70)(2)(3)13(4)
Other comprehensive income (loss)(21)(4)(3)(1)2
Comprehensive income (loss), net of tax, attributable to parent:(92)(6)(6)12(2)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: